Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Feasibility, Acceptability, and Preliminary Outcomes of a Group-Based Brief Cognitive-Behavioral Therapy Protocol for Suicide Prevention in a Brazilian Public Mental Health Service: A Mixed-Methods Pilot Study.

Created on 15 Oct 2026

Authors

Letícia Lopes de Figueiredo, Loren Beiram, Jônatas Magalhães Santos, Mariana Filippini Cacciacarro, Letícia Almeida Silveira Camolesi, Justin C Baker, Eurípedes Constantino Miguel, Craig J Bryan, Rodolfo Furlan Damiano

Published in

Suicide & life-threatening behavior. Volume 56. Issue 5. Pages e70143.

Abstract

We evaluated the feasibility, acceptability, and preliminary outcomes of group-adapted brief cognitive-behavioral therapy for suicide prevention (BCBT) in a Brazilian public psychiatric outpatient service.
This single-arm, nonrandomized, mixed-methods pilot enrolled 27 adults across two cohorts receiving 16 weekly group sessions. Feasibility and acceptability were assessed, and suicidal ideation was monitored weekly using the Beck Scale for Suicide Ideation (BSI).
Enrollment targets were met; 70.4% had ≥ 4 recorded sessions, and no intervention-related adverse events were recorded. All six questionnaire respondents rated recommendation at 8-10. Four provided qualitative responses, highlighting shared suffering recognition and an interpretive theme of hope instillation. The linear BSI slope was nonsignificant (B = -0.29, p = 0.129); multiple imputation yielded B = -0.36 (p = 0.018). An exploratory quadratic model indicated greater decline later in treatment (p = 0.008). Among 18 participants with ≥ 4 recorded sessions and baseline BSI, scores decreased by 8.2 points from baseline to the last observation (d = -0.67; p = 0.011).
Group-adapted BCBT showed preliminary feasibility and acceptability, with uncontrolled signals of reduced suicidal ideation. Controlled evaluation is needed to establish efficacy.

PMID:
42876252
Bibliographic data and abstract were imported from PubMed on 15 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 27
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement